BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3309762)

  • 1. [Supportive therapy with xenogenous peptides in patients with metastatic breast cancer undergoing aggressive chemotherapy (modified AC-protocol): a prospective, randomized double-blind study].
    Lange OF
    Onkologie; 1987 Jun; 10(3 Suppl):40-3. PubMed ID: 3309762
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant-preoperative-chemotherapy for breast cancer--preliminary report of the Vancouver trial.
    Ragaz J; Baird R; Rebbeck P; Coldman A; Goldie J
    Prog Clin Biol Res; 1985; 201():77-87. PubMed ID: 3912768
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant intermittent chemo-immunotherapy of breast cancer. A prospective study.
    Schreml W; Betzler M; Lang M; Lohrman HP; Kubitza P; Schlag P; Flad HD; Herfarth C; Heimpel H
    Eur J Cancer (1965); 1980; Suppl 1():165-8. PubMed ID: 7032927
    [No Abstract]   [Full Text] [Related]  

  • 5. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
    Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
    Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
    deMagalhaes-Silverman M; Bloom E; Lembersky B; Lister J; Pincus S; Rybka W; Voloshin M; Wilson J; Ball E
    Clin Cancer Res; 1997 Feb; 3(2):193-7. PubMed ID: 9815672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
    Bellon JR; Come SE; Gelman RS; Henderson IC; Shulman LN; Silver BJ; Harris JR; Recht A
    J Clin Oncol; 2005 Mar; 23(9):1934-40. PubMed ID: 15774786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective: breast cancer adjuvant therapy after two decades. Clinical progress but a "partial circle" in investigation.
    Chlebowski RT
    Am J Clin Oncol; 1993 Dec; 16(6):532-5. PubMed ID: 8256773
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective randomized clinical trial: protoadjuvant chemotherapy vs. protoadjuvant radiotherapy in breast cancer stages T3/4, N+/-, M0.
    Rainer H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):599-602. PubMed ID: 3913160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer].
    Semiglazov VF; Moiseenko VM; Ivanova OA
    Vopr Onkol; 1986; 32(8):31-4. PubMed ID: 3532535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 14. Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group Trial.
    Carpenter JT; Smalley RV; Raney M; Vogel CL; Weiner RS
    Cancer Treat Rep; 1986 Sep; 70(9):1073-9. PubMed ID: 3527407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the treatment of stage III breast cancer.
    Spangenberg JP; Nel CJ; Anderson JD; Doman MJ
    S Afr J Surg; 1986 Jun; 24(2):57-60. PubMed ID: 3726673
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of cytostatic therapy on bone metabolism].
    Heytmanek G; Sevelda P; Enzelsberger H; Metka M; Kubista E
    Gynakol Rundsch; 1988; 28 Suppl 2():193-5. PubMed ID: 3069624
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy of axillary node-negative carcinoma of the breast using doxorubicin and cyclophosphamide.
    Brooks RJ; Jones SE; Salmon SE; Chase EM; Davis SL; Moon TE; Giordano GF; Ketchel SJ; Jackson RA
    NCI Monogr; 1986; (1):135-7. PubMed ID: 3534586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
    Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
    Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
    Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-77-S17-80. PubMed ID: 9374100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.